Clearmind Medicine Inc. (NASDAQ: CMND)
$1.2000
N/A ( -0.83% ) 24.3K
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
Market Data
Open
$1.2000
Previous close
$1.2000
Volume
24.3K
Market cap
$5.30M
Day range
$1.1700 - $1.2200
52 week range
$0.9205 - $3.5800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Form 6-K | 13 | Dec 06, 2024 |
6-k | Form 6-K | 3 | Nov 20, 2024 |
6-k | Form 6-K | 2 | Oct 10, 2024 |
6-k | Form 6-K | 1 | Sep 26, 2024 |
6-k | Form 6-K | 74 | Sep 16, 2024 |
6-k | Form 6-K | 3 | Sep 16, 2024 |
6-k | Form 6-K | 3 | Sep 12, 2024 |
6-k | Form 6-K | 3 | Sep 06, 2024 |
6-k | Form 6-K | 3 | Aug 29, 2024 |
6-k | Form 6-K | 3 | Aug 21, 2024 |